Neuroprotective effects of riluzole in Huntington’s disease

被引:0
作者
Ferdinando Squitieri
Andrea Ciammola
Claudio Colonnese
Andrea Ciarmiello
机构
[1] IRCCS Neuromed,Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Center
[2] IRCCS Istituto Auxologico Italiano,Nuclear Medicine Unit
[3] IRCCS Pascale,Neurogenetics Unit, IRCCS Neuromed
[4] Centre for Rare Diseases,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词
Poly Glutamine; Riluzole; Serum BDNF; Serum BDNF Level; Untreated Subject;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:221 / 222
页数:1
相关论文
共 18 条
[1]  
Bergerot A(2004)Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury Exp Neurol 187 359-366
[2]  
Shortland PJ(2002)Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus FASEB J 16 1328-1330
[3]  
Anand P(2004)Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 127-138
[4]  
Katoh-Semba R(2007)Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington’s disease patients Am J Med Genet B Neuropsychiatr Genet 144B 574-577
[5]  
Asano T(2006)Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease J Nucl Med 47 215-222
[6]  
Ueda H(1997)Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach Magn Reson Med 37 84-93
[7]  
Gauthier LR(undefined)undefined undefined undefined undefined-undefined
[8]  
Charrin BC(undefined)undefined undefined undefined undefined-undefined
[9]  
Borrell-Pages M(undefined)undefined undefined undefined undefined-undefined
[10]  
Ciammola A(undefined)undefined undefined undefined undefined-undefined